GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 201 filers reported holding GENMAB A/S in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $368,000 | -29.1% | 11,350 | -21.0% | 0.08% | -17.8% |
| Q1 2022 | $519,000 | -17.1% | 14,369 | -9.2% | 0.10% | -15.1% |
| Q4 2021 | $626,000 | -47.1% | 15,832 | -41.6% | 0.12% | -48.3% |
| Q3 2021 | $1,184,000 | -12.4% | 27,090 | -18.1% | 0.23% | -14.2% |
| Q2 2021 | $1,351,000 | -50.7% | 33,080 | -60.3% | 0.27% | -56.2% |
| Q1 2021 | $2,738,000 | -22.9% | 83,414 | -14.0% | 0.61% | -28.8% |
| Q3 2020 | $3,552,000 | +7.9% | 97,012 | -0.1% | 0.86% | +0.7% |
| Q2 2020 | $3,292,000 | – | 97,135 | – | 0.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 52,148 | $1,839,260 | 1.67% |
| Ativo Capital Management LLC | 28,442 | $1,003,132 | 1.13% |
| HARDING LOEVNER LP | 3,204,230 | $113,013,183 | 0.75% |
| Hardman Johnston Global Advisors LLC | 592,318 | $20,891,056 | 0.70% |
| Yorktown Management & Research Co Inc | 16,600 | $585,482 | 0.66% |
| TORRAY INVESTMENT PARTNERS LLC | 104,516 | $3,686,279 | 0.65% |
| First Light Asset Management, LLC | 157,147 | $5,542,575 | 0.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 44,300 | $1,561,575 | 0.53% |
| Capricorn Fund Managers Ltd | 37,007 | $1,305,237 | 0.45% |
| Legacy Wealth Asset Management, LLC | 29,496 | $1,040,324 | 0.38% |